Evidence map›Paper›PMID 40913735›Full record

ArticleInternational orthopaedics2025

Ortho-bridge system for the treatment of Vancouver type B1 periprosthetic femoral fractures based on three dimensional printing.

Huiqin Yang, Md Miftahul Mithu, Xin Xin, Zhongxin Wang, Weiyu Duan, Chengbin Lu, Benmo Xu, Jiazheng Huang, Yunfeng Ren, Zhongxiong Wu and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Huiqin YangDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Md Miftahul MithuDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Xin XinKunming Medical University, Kunming, 650500, Yunnan, China.
Zhongxin WangKunming Medical University, Kunming, 650500, Yunnan, China.
Weiyu DuanKunming Medical University, Kunming, 650500, Yunnan, China.
Chengbin LuKunming Medical University, Kunming, 650500, Yunnan, China.
Benmo XuKunming Medical University, Kunming, 650500, Yunnan, China.
Jiazheng HuangDepartment of Orthopedics, Handan First Hospital, Handan, 056000, China.
Yunfeng RenDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Zhongxiong WuDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Qi PuDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Hongkun YangDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Jipeng LuDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Ying XiongDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China.
Zhuoyuan ChenDepartment of Orthopedics, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, P. R. China. chenzhuoyuan@kmmu.edu.cn.
Fang YangDepartment of the Second Medical Oncology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China. 15198729531@163.com.

Funding

Applied Basic Research Foundation of Yunnan Province (202301AU070104) 202301AU070104Applied Basic Research Foundation of Yunnan Province and Kunming Medical University (202301AY070001-180) 202301AY070001-180Kunming Health Commission Health Science and Technology Talent Project (2023-SW-65) 2023-SW-65Project of Scientific Research Fund of the Department of Education of Yunnan Province, Department of Education of Yunnan Province, project number: 2025J0261, "The Role of LncRNA BLACAT1 in the Progression and Metabolic Reprogramming of Osteosarcoma". 2025J0261
6 · The paper itself

Abstract

objectiveThis study aims to evaluate the clinical outcomes of Vancouver B1 periprosthetic femoral fractures (PFF) treated with the Ortho-bridge system (OBS) internal fixation and assess the potential benefits of 3D printing technology in preoperative planning and surgical execution for these cases.

methodThis retrospective study analyzed 55 consecutive Vancouver B1 periprosthetic femoral fracture cases treated surgically at Yan'an Affiliated Hospital of Kunming Medical University (2014-2022) with minimum 1-year follow-up. Patients were divided into conventional ORIF (n = 21) and OBS fixation groups (n = 34), with the OBS group further stratified into standard procedure (n = 18) and 3D-printing-assisted (n = 16) subgroups. Treatment outcomes were evaluated using Harris Hip Scores, while surgical parameters including incision length, operative time, and intraoperative blood loss were compared between groups.

resultThe study included 55 Vancouver B1 PFF cases (ORIF = 21, OBS = 34), with the OBS group further divided into conventional (n = 18) and 3D-assisted (n = 16) subgroups. While no significant differences existed between ORIF and OBS groups in operative time (159.52 ± 56.35 vs. 165.03 ± 49.09 min), blood loss (734.29 ± 545.89 vs. 682.06 ± 341.88 mL), or incision length (22.62 ± 5.84 vs. 22.24 ± 6.72 cm), the 3D-assisted OBS subgroup demonstrated 18.6% shorter operative time (147.19 ± 39.54 vs. 180.89 ± 52.28 min, p < 0.05) and 26.0% reduced blood loss (575.00 ± 327.45 vs. 777.22 ± 334.52 mL, p < 0.05) compared to conventional OBS. All fractures healed (mean 4.78 months) with no revisions, though DVT occurred in two ORIF and two OBS cases. Functional outcomes were comparable across groups (Harris scores: ORIF 74.38 ± 9.39, OBS 74.18 ± 12.08; 3D-assisted OBS 75.31 ± 11.09 vs. conventional OBS 73.17 ± 13.13, p > 0.05).

conclusionThe OBS internal fixation system demonstrates comparable efficacy to conventional ORIF for Vancouver B1 periprosthetic fractures, with equivalent functional outcomes and fracture healing rates. When combined with 3D-printing-assisted preoperative planning, OBS offers significant advantages including reduced operative time (18.6%) and decreased blood loss (26.0%). These findings suggest that the OBS system, particularly when enhanced by 3D printing technology, represents a viable alternative for PFF management, providing stable fixation while maintaining biological osteosynthesis principles.

Indexed as

Femoral FracturesFracture Fixation, InternalPeriprosthetic FracturesPrinting, Three-DimensionalAdultAgedFemaleHumansMaleMiddle AgedOperative TimeRetrospective StudiesTreatment Outcome3D printingInternal fixation of fracturesOrtho-bridge system internal fixationPeriprosthetic fractures of the femurVancouver B1 type

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.